Ovid Therapeutics
OVID
OVID
77 hedge funds and large institutions have $167M invested in Ovid Therapeutics in 2023 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 17 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
77
Holders Change
+13
Holders Change %
+20.31%
% of All Funds
1.13%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
25
Reduced
17
Closed
3
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
-$99K
Top Buyers
| 1 |
BOCH
Blue Owl Capital Holdings
New York
|
+$2.78M |
| 2 |
BlackRock
New York
|
+$2.57M |
| 3 |
FWM
FFT Wealth Management
Philadelphia,
Pennsylvania
|
+$1.27M |
| 4 |
Morgan Stanley
New York
|
+$724K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$324K |
